Position in JNJ
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$67,255,065
+$3,716,554 QoQ
Shares Held
264,815
+1.9% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
1.53%
of 13F equity value
Holder Rank
#386
of 4,676 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avanza Fonder AB holds $214,153,018 across 9 Drug Manufacturers - General names. JNJ ranks #1 (31.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
264,815 | $67,255,065 | |
| 2 | MRK |
Merck & Co., Inc.
|
300,014 | $38,551,798 | |
| 3 | LLY |
ELI LILLY & Co
|
30,594 | $36,695,363 | |
| 4 | AMGN |
Amgen Inc
|
63,010 | $22,817,180 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
142,643 | $18,021,516 | |
| 6 | PFE |
Pfizer Inc
|
634,756 | $15,284,924 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
210,840 | $12,148,600 | |
| 8 | BIIB |
Biogen Inc.
|
11,760 | $2,540,864 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,255,065 | 264,815 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $63,538,511 | 259,935 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $53,612,673 | 259,061 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $46,377,435 | 250,121 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $35,842,329 | 234,647 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $37,824,952 | 228,081 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $37,420,280 | 258,749 | Shares | Sole | 2025-01-15 | |
| No filing history on record for this holder in this stock. | ||||||